المؤلفون: Sérgio Saldanha Menna-Barreto

المصدر: Repositório Institucional da UFRGS
Universidade Federal do Rio Grande do Sul (UFRGS)
instacron:UFRGS
Jornal Brasileiro de Pneumologia v.31 n.6 2005
Jornal Brasileiro de Pneumologia
Sociedade Brasileira de Pneumologia e Tisiologia (SBPT)
instacron:SBPT

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Acute exacerbation of chronic obstructive pulmonary disease, Embolia pulmonar/diagnóstico, Exacerbation, Relação ventilação-perfusão, Pulmonary disease, Pulmonary embolism/ epidemiology, Internal medicine, Doença pulmonar obstrutiva crônica, medicine, In patient, Embolia pulmonar/epidemiologia, Doença pulmonar obstrutiva crônica/complicações, business.industry, Ventilation-perfusion ratio, Diagnostic algorithms, Lung scan, Pulmonary disease chronic obstructive/complications, medicine.disease, Surgery, Concomitant, Cardiology, Embolia pulmonar, business, Clinical risk factor, Pulmonary embolism/diagnosis

الوصف: Tromboembolia pulmonar aguda e exacerbação aguda de doença pulmonar obstrutiva crônica são doenças comuns. A doença pulmonar obstrutiva crônica é um fator clínico de risco para tromboembolia pulmonar aguda. As apresentações clínicas da tromboembolia pulmonar aguda e da exacerbação aguda da doença pulmonar obstrutiva crônica freqüentemente mimetizamse tanto que pode ser difícil distingui-las. Anormalidades estruturais nos pulmões com doença pulmonar obstrutiva crônica tornam também difícil a interpretação de testes não invasivos de diagnóstico, como o mapeamento de ventilação e perfusão pulmonares. Assim, diagnosticar tromboembolia pulmonar aguda em pacientes com doença pulmonar obstrutiva crônica é uma tarefa desafiadora. Com o objetivo de atualizar o assunto e oferecer sugestões de conduta, nós avaliamos artigos abordando este tema, incluindo relatos e séries de casos, abordagens diagnósticas de tromboembolia pulmonar aguda e fizemos algumas reflexões. A probabilidade clínica de tromboembolia pulmonar aguda em cenários de doença pulmonar obstrutiva crônica é usualmente intermediária, o mapeamento de ventilação e perfusão pulmonares é predominantemente de probabilidade intermediária e os algoritmos de conduta os deveriam assim considerar. Pulmonary thromboembolism and exacerbation of chronic obstructive pulmonary disease are common conditions. Chronic obstructive pulmonary disease is a clinical risk factor for pulmonary thromboembolism. The presentation of acute pulmonary thromboembolism and acute exacerbation of chronic obstructive pulmonary disease often mimic each other so closely that they cannot be distinguished clinically. The structural abnormalities of the lungs in chronic obstructive pulmonary disease make also difficult to interpret the results of noninvasive tests like ventilation-perfusion lung scans. Therefore, diagnosing acute pulmonary thromboembolism in patients with underlying chronic obstructive pulmonary disease is a challenging task. In order to update knowledge of the subject and offer suggestions regarding conduct, we evaluated various studies addressing this theme, including case reports and case series. In addition, we reviewed diagnostic approaches to acute pulmonary thromboembolism, and we reflect upon that topic. The clinical probability of pulmonary thromboembolism concomitant to chronic obstructive pulmonary disease is typically intermediate, as is positivity on the ventilation-perfusion lung scan. Diagnostic algorithms should take that into consideration.

وصف الملف: application/pdf; text/html

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63ab65bc1e9b1324ec238d48213a1d7f

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Tommelein E, Mehuys E, Van Hees T, Adriaens E, Van Bortel L, Christiaens T, Van Tongelen I, Jp, Remon, Boussery K, Guy Brusselle

المساهمون: Pharmaceutical and Pharmacological Sciences, Pulmonary Medicine

المصدر: Europe PubMed Central
British Journal of Clinical Pharmacology, 77(5), 756-766. Wiley-Blackwell Publishing Ltd

مصطلحات موضوعية: Male, Pulmonary Disease, Chronic Obstructive/complications, Humans, Female, health status, Single-Blind Method, Community Pharmacy Services, Middle Aged, Aged, Medication Adherence

الوصف: AIMS: Few well-designed randomized controlled trials have been conducted regarding the impact of community pharmacist interventions on pharmacotherapeutic monitoring of patients with chronic obstructive pulmonary disease (COPD). We assessed the effectiveness of a pharmaceutical care programme for patients with COPD. METHODS: The pharmaceutical care for patients with COPD (PHARMACOP) trial is a single-blind 3 month randomized controlled trial, conducted in 170 community pharmacies in Belgium, enrolling patients prescribed daily COPD medication, aged ≥ 50 years and with a smoking history of ≥ 10 pack-years. A computer-generated randomization sequence allocated patients to an intervention group (n = 371), receiving protocol-defined pharmacist care, or a control group (n = 363), receiving usual pharmacist care (1:1 ratio, stratified by centre). Interventions focusing on inhalation technique and adherence to maintenance therapy were carried out at start of the trial and at 1 month follow-up. Primary outcomes wereinhalation technique and medication adherence. Secondary outcomes were exacerbation rate, dyspnoea, COPD-specific and generic health status and smoking behaviour. RESULTS: From December 2010 to April 2011, 734 patients were enrolled. Forty-two patients (5.7%) were lost to follow-up. At the end of the trial, inhalation score [mean estimated difference (Δ),13.5%; 95% confidence interval (CI), 10.8-16.1; P < 0.0001] and medication adherence (Δ, 8.51%; 95% CI, 4.63-12.4; P < 0.0001) were significantly higher in the intervention group compared with the control group. In the intervention group, a significantly lower hospitalization rate was observed (9 vs. 35; rate ratio, 0.28; 95% CI, 0.12-0.64; P = 0.003). No other significant between-group differences were observed. CONCLUSIONS: Pragmatic pharmacist care programmes improve the pharmacotherapeutic regimen in patients with COPD and could reduce hospitalization rates.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::d9007651cfbde5a4acf1314adac0c3d2
http://europepmc.org/abstract/med/24117908

المؤلفون: Ida Stisen Fogh-Andersen, Ingeborg Farver-Vestergaard, Christian Møller Pedersen, Elisabeth Shirin Tehrani, Anders Løkke

المصدر: University of Southern Denmark
Fogh-Andersen, I S, Farver-Vestergaard, I, Pedersen, C M, Tehrani, E S & Løkke Ottesen, A 2022, ' Udredning og behandling af angst og depression hos patienter med KOL ', Ugeskrift for Laeger, bind 184, nr. 1, V09200679 . < https://ugeskriftet.dk/videnskab/udredning-og-behandling-af-angst-og-depression-hos-patienter-med-kol >
Fogh-Andersen, I S, Farver-Vestergaard, I, Pedersen, C M, Tehrani, E & Ottesen, A L 2021, ' Udredning og behandling af angst og depression hos patienter med KOL ', Ugeskrift for Læger, bind 183, nr. 4, V09200679 . < https://ugeskriftet.dk/videnskab/udredning-og-behandling-af-angst-og-depression-hos-patienter-med-kol >

مصطلحات موضوعية: Anxiety Disorders/diagnosis, Depression/diagnosis, Pulmonary Disease, Chronic Obstructive/complications, fungi, Quality of Life, Humans, food and beverages, Anxiety/diagnosis, respiratory tract diseases

الوصف: An estimated 33 percent of patients with COPD have co-morbidities in terms of anxiety and/or depression (A and D). A large proportion of these patients are not diagnosed, mainly because some of the core symptoms of A and D can be misinterpreted as being caused by COPD. Untreated A and D in patients with COPD can have a negative impact on several parameters e.g. dyspnoea and mortality. On this basis, this review argues, that special focus in primary care and hospitals on diagnosing and treating A and D in patients with COPD using anti-depressants or cognitive therapy can reduce symptom burden and significantly improve quality of life.

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::df1682b725951241e2552b942c6514a3
https://portal.findresearcher.sdu.dk/en/publications/e2832178-0dc3-4fcb-aafc-7d669048bcac

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.